t-guy,
I don't think it is MCNS's approach, it's the drug companies' approach.
Anyway, technically speaking the stock is at a crucial short-term point. Refused to break out above the downtrend line and the 13-bar Exp. MA on Friday. The MA is at 6.25 on the daily chart and the trend line is a shade above it, creating strong resistance. The stock could well be heading down from here. An uptick in volume would be of interest, perhaps signalling a move up. Even so, it could still follow the downtrend line, just on the other side.
Action from the Company might possibly help the stock, but that doesn't seem to be in the cards.
Cheers,
Bond |
